Integrated OTC Stock Market Value

INBP -  USA Stock  

USD 1.08  0.01  0.92%

Integrated Biopharma's market value is the price at which a share of Integrated Biopharma stock trades on a public exchange. It measures the collective expectations of Integrated Biopharma investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Integrated Biopharma and determine expected loss or profit from investing in Integrated Biopharma over a given investment horizon. Please see Integrated Biopharma Hype Analysis, Integrated Biopharma Correlation, Integrated Biopharma Valuation, Integrated Biopharma Volatility, as well as analyze Integrated Biopharma Alpha and Beta and Integrated Biopharma Performance.

The market value of Integrated Biopharma is measured differently than its book value, which is the value of Integrated that is recorded on the company's balance sheet. Investors also form their own opinion of Integrated Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Integrated Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integrated Biopharma's market value can be influenced by many factors that don't directly affect Integrated Biopharma underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integrated Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Integrated Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integrated Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Integrated Biopharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Integrated Biopharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Integrated Biopharma.
No Change 0.00  0.0 
In 30 days
If you would invest  0.00  in Integrated Biopharma on September 23, 2021 and sell it all today you would earn a total of 0.00 from holding Integrated Biopharma or generate 0.0% return on investment in Integrated Biopharma over 30 days. Integrated Biopharma is related to or competes with Aadi Biosciences, Abeona Therapeutics, Arca Biopharma, Acumen Pharmaceuticals, Arbutus Biopharma, Abvc Biopharma, and Acadia Pharmaceutica. Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutr...

Integrated Biopharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Integrated Biopharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Integrated Biopharma upside and downside potential and time the market with a certain degree of confidence.

Integrated Biopharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Integrated Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Integrated Biopharma's standard deviation. In reality, there are many statistical measures that can use Integrated Biopharma historical prices to predict the future Integrated Biopharma's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Integrated Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Integrated Biopharma in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
Band Projection (param)
LowerMiddle BandUpper
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Integrated Biopharma. Your research has to be compared to or analyzed against Integrated Biopharma's peers to derive any actionable benefits. When done correctly, Integrated Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Integrated Biopharma.

Integrated Biopharma Backtested Returns

We consider Integrated Biopharma dangerous. Integrated Biopharma holds Efficiency (Sharpe) Ratio of 0.0289, which attests that the entity had 0.0289% of return per unit of risk over the last 3 months. Our standpoint towards determining the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-seven technical indicators for Integrated Biopharma, which you can use to evaluate the future volatility of the firm. Please check out Integrated Biopharma Market Risk Adjusted Performance of (0.75), downside deviation of 2.98, and Risk Adjusted Performance of 0.0312 to validate if the risk estimate we provide is consistent with the expected return of 0.0894%.
Integrated Biopharma has performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.125, which attests to not very significant fluctuations relative to the market. Let's try to break down what Integrated's beta means in this case. As returns on the market increase, returns on owning Integrated Biopharma are expected to decrease at a much lower rate. During the bear market, Integrated Biopharma is likely to outperform the market. Although it is extremely important to respect Integrated Biopharma current price history, it is better to be realistic regarding the information on equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Integrated Biopharma technical indicators, you can presently evaluate if the expected return of 0.0894% will be sustainable into the future. Integrated Biopharma right now retains a risk of 3.09%. Please check out Integrated Biopharma potential upside, as well as the relationship between the kurtosis and day typical price to decide if Integrated Biopharma will be following its current trending patterns.
AdviceVolatility TrendExposureCorrelations



Very weak reverse predictability

Integrated Biopharma has very weak reverse predictability. Overlapping area represents the amount of predictability between Integrated Biopharma time series from 23rd of September 2021 to 8th of October 2021 and 8th of October 2021 to 23rd of October 2021. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Integrated Biopharma price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current Integrated Biopharma price fluctuation can be explain by its past prices. Given that Integrated Biopharma has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of Integrated Biopharma for similar time interval.
Correlation Coefficient-0.05
Spearman Rank Test-0.81
Residual Average0.0
Price Variance0.0

Integrated Biopharma lagged returns against current returns

Autocorrelation, which is Integrated Biopharma otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Integrated Biopharma's otc stock expected returns. We can calculate the autocorrelation of Integrated Biopharma returns to help us make a trade decision. For example, suppose you find that Integrated Biopharma otc stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 

Integrated Biopharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Integrated Biopharma otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Integrated Biopharma otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Integrated Biopharma otc stock over time.
 Current vs Lagged Prices 

Integrated Biopharma Lagged Returns

When evaluating Integrated Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Integrated Biopharma otc stock have on its future price. Integrated Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Integrated Biopharma autocorrelation shows the relationship between Integrated Biopharma otc stock current value and its past values and can show if there is a momentum factor associated with investing in Integrated Biopharma.
 Regressed Prices 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Integrated Biopharma without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pattern Recognition Now


Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Integrated Biopharma using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Integrated Biopharma Hype Analysis, Integrated Biopharma Correlation, Integrated Biopharma Valuation, Integrated Biopharma Volatility, as well as analyze Integrated Biopharma Alpha and Beta and Integrated Biopharma Performance. Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Integrated OTC Stock analysis

When running Integrated Biopharma price analysis, check to measure Integrated Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Biopharma is operating at the current time. Most of Integrated Biopharma's value examination focuses on studying past and present price action to predict the probability of Integrated Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Integrated Biopharma's price. Additionally, you may evaluate how the addition of Integrated Biopharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Integrated Biopharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Integrated Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Integrated Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...